E N D
1. 1 Psychopharmacology Therapeutic vs. toxic dosage levels
Side effects
Adverse effects
Interactions
Use with the elderly, during Use during pregnancy
Patient teaching
nonpsychopharmacological interventions
2. 2 Genetic pathway responsible for vulnerability is present in one twin but not the otherGenetic pathway responsible for vulnerability is present in one twin but not the other
3. 3 Neurotransmitter Neurotransmitter - combine with a specific receptor; Relay a chemical message to the receptor cell
Drugs act on neurotransmitters
Agonist – activating cell function; to accelerate or slow cellular processes
Antagonist – prevent natural or other substances from activating cell function
Affinity – binding between drug and receptor
Refractoriness - desensitization of cells to a drug over time
Neurotransmitter - combine with a specific receptor; enhance or inhibit nerve message transmission; Relay a chemical message to the receptor cell
Agonist is a drug that initiates a therapeutic effect by binding to a receptor. It may affect other body functions. Ie. Lithium -> thyroid or kidney problem
Refractoriness – desensitization of cells to a drug over time Neurotransmitter - combine with a specific receptor; enhance or inhibit nerve message transmission; Relay a chemical message to the receptor cell
Agonist is a drug that initiates a therapeutic effect by binding to a receptor. It may affect other body functions. Ie. Lithium -> thyroid or kidney problem
Refractoriness – desensitization of cells to a drug over time
4. 4 Neurotransmitters and Related Mental Disorders Dopamine ?
Norepinephrine ?
Serotonin ?
Acetylcholine ?
Gamma-aminobutyric acid (GABA) ?
Schizophrenia
Depression
Depression
Alzheimer’s disease
Anxiety
Dopamine is important in conceptualizing the pathology & tx of schizophrenia & parkinsonism.
Patients who are taking antiparkinson agents should not stop taking the drug abruptly
Dopamine depletion -> impairment in complex motor activities
Norepinephrine inbalance -> mood disorderDopamine is important in conceptualizing the pathology & tx of schizophrenia & parkinsonism.
Patients who are taking antiparkinson agents should not stop taking the drug abruptly
Dopamine depletion -> impairment in complex motor activities
Norepinephrine inbalance -> mood disorder
5. 5 Pharmacokinetics - Absorption PO, IV, IM,…- Absorption
qid, tid, bid, … - drug level in the blood
Individual condition -
sex - female: fat
age - older:
health - congestive heart failure, GI,
Others - exercise
6. 6 Pharmacokinetics - Distribution Target tissue
Cardiac output - electric imbalance, CHF, chr pulmonary dis
Serum protein binding
Half-life of the drug
Pregnancy
Lipid solubility - cross BBB
Steady state - 4-5 half-lifeLipid solubility - cross BBB
Steady state - 4-5 half-life
7. 7 Pharmacokinetics - Metabolism Break down or metabolize into other compound - liver
convert into other active substance – liver
8. 8 Pharmacokinetics - Excretion Proper excretion = less toxicity
Kidney - main excretion organ
Others - GI, skin, lungs, sweat glands
Tissue perfusion rate - shock, hemorrhage
Diseases - renal, liver ...
Urinary pH - acidic urine -amphetamine
alkaline urine- barbiturates
9. 9 Phases of Treatment Initiation
Stabilization
Maintenance
Medication-free
10. 10 Nursing Responsibilities Monitor the S & S of the disease state
Monitor for common, expected or worrisome side effects of medications
Preventing adverse drug reactions
Evaluate compliance
Judge the appropriateness of the regimen
Recommend needed changes
Provide pt & family education Realistic outcome of the teaching is: pt able to state the purpose, dose, significant side effects of each drugRealistic outcome of the teaching is: pt able to state the purpose, dose, significant side effects of each drug
11. 11 Patient Education Compliance - effectiveness, symptom control
Side-effect - inevitable, unpleasant, temporary; only a few are life threatening
Education - encourages compliance; Medications are not magic bullet
Balance with information - too much
or inappropriate
Health beliefs model- what is the benefit of taking med
Regular checkups and test
92% of rehospitalizations are r/t nonadherence to medication schedule
Education needs- 72% - do not understand their medication
8% - know the name, dosage schedule, & desired effect; what effects are visible. what can be felt, and what the possibilities are of becoming drug-dependent
92% of rehospitalizations are r/t nonadherence to medication schedule
Education needs- 72% - do not understand their medication
8% - know the name, dosage schedule, & desired effect; what effects are visible. what can be felt, and what the possibilities are of becoming drug-dependent
12. 12 Classes of psychotropic medication Antipsychotic medications
Antidepressant medications
Mood-stabilizing drugs
Anti-anxiety medications
Psychostimulants
13. 13 Antipsychotics - typical 1950 - Chlorpromazine (Thorazine)
Mechanism - Block dopamine receptors
effective in treating (+) symptoms
ie. alterations of perception- hallucinations
thought disturbance - delusion
activity - agitation
14. 14 Atypical agents 1980’s -
Targets dopamine and serotonin, may work on both (+) & (-) symptoms
Better tolerated, less side effects, better compliance, less cognitive impairment, better efficacy in negative symptoms of schizophrenia
15. 15 Typical & Atypical Phenothiazines
Thorazine
200-800 mg qd
half-life: 30 hours
Peak 2-4 hours
Non-phenothiazines
Haldol
1-15 mg qd
half-life: 21-24 hours
Higher risk of EPSs Clozaril
150-450 mg qd,
watch for fever, agranulocytosis
Risperdal
2-8 mg qd
Less sedation
Zyprexa
5-10 mg qd
smaller dose for the elderly & liver dis. pt
Clozaril is metabolized in the liver by the cytochrome enzyme system, dosage reductions may be required in pts receiving other drugs metabolized by the same system. That includes antidepressant medications, carbomazepine, and the antiarrhythmics propafenone (Rythmol), flecainide (Tambocor), and quinidine (Quinidex).
Olanzapine (Zyprexa) serum half-life increases by about 50% in pts over 65 & in pts with liver dysfunciton. Those clients may require smaller than average doses.Clozaril is metabolized in the liver by the cytochrome enzyme system, dosage reductions may be required in pts receiving other drugs metabolized by the same system. That includes antidepressant medications, carbomazepine, and the antiarrhythmics propafenone (Rythmol), flecainide (Tambocor), and quinidine (Quinidex).
Olanzapine (Zyprexa) serum half-life increases by about 50% in pts over 65 & in pts with liver dysfunciton. Those clients may require smaller than average doses.
16. 16 Neurological complications of antipsychotics Pseudoparkinsonism - muscle rigidity
Extrapyramidal Side Effects (EPSEs)-
Akathisia* - motor restlessness
Dyskinesia - jerky motion
Dystonia -muscle rigidity; life-threatening
Tardive dyskinesia – facial grimacing tics, tongue writhing, lip smacking, puckering…
- irreversible, high dose, older, females, TD includes abnormal movements in the neck, trunk, and limbs
Primary hazard – EPSEs & tardive dyskinesiaTD includes abnormal movements in the neck, trunk, and limbs
Primary hazard – EPSEs & tardive dyskinesia
17. 17 Other adverse effects (I) Anticholinergic effect –
dry mouth, blurred vision, constipation,
Neuroleptic maliganant syndrome (NMS) - rare, life-threatening
altered consciousness, hyperthermia, muscle rigidity, tachycardia, sweating
discontinue the medication
reverse the dopamine-blocking effects of antipsychotics (ie bromocriptine) or muscle relaxant (ie dantrolene)
18. 18 Other adverse effects (II) Seizures - threshold ?
Hyperprolactinemia - breast engorgement, falactorrhea, amenorrhea, impotence, azospermia
Hepatic changes - jaundice, nausea, fever, chill, general malaise, itching
Photosensitivity
Weight gain - 3-9 lbs
19. 19 Interventions for EPSEs Tolerance usually ? by the 3rd month
Lower dose of drug
Add a drug to treat EPSE, then taper after 3 M on the antipsychotics
Use a drug with a lower EPSE profile
Pt education and support
20. 20 Interventions for Dystonia Occur suddenly; frightening; painful
Common in children and young males
With high potency drugs
Medication - IV > PO;
Have respiratory support available
taper antipsychotics gradually to prevent withdrawal dyskinesia
21. 21 Neuroleptic Malignant Syndrome Drug-induced disorder;
Be recognized in 1980s
Incidence – 0.2%; uncommon but potentially life-threatening
Risk factors- dehydration, agitation, catatonia, mood disorders, organic brain syndromes, drug or alcohol withdrawal states, previous NMS episodes, drugs given by injection Exercise -> dehydrationExercise -> dehydration
22. 22 Characteristics of NMS Disturbances in mental status, temperature regulation, & autonomic and extrapyramidal functions
Mental Status – catatonia
Vital signs – tachycardia, unstable BP
Extrapyramidal functions – tremors, dysarthria, dysphagia, drooling
Lab – increased WBC, elevated blood enzymes ie. Creatine phosphokinase,
Dysarthria – difficulty in articulating single sounds or phonemes of speech
Disphagia – difficulty in swallowingDysarthria – difficulty in articulating single sounds or phonemes of speech
Disphagia – difficulty in swallowing
23. 23 Interventions for NMS Potential fatal - tachycardia, fever, sweating, muscle rigidity, incontinence, stupor, aspiration pneumonia, leukocytosis, renal failure,
Common with high potency drugs and in dehydrated pts
Discontinue all drugs,
supportive symptomatic care (H2O; BT?; hemodialysis)
antipsychotics can be reintroduced later
24. 24 Interventions for Agranulocytosis Emergency case; occur abruptly
Fever, malaise, ulcerative sore throat, leukopenia
High incidence with clozapine (1-2%) - 1wk prescription a time - check CBC
Discontinue drug immediately
May need isolation and antibiotics
25. 25 Interventions for Photosensitivity Use sunscreen and sunglasses
Cover body with clothing
Reassurance
normal vision typically returns in a few days
tolerance develops
26. 26 Interventions for Anticholinergic effect S/S: constipation, dry mouth, blurred vision, orthostatic hypotension, tachycardia, urinary retention, nasal congestion
Avoid hazard task
Fluid, mouth rinse, hard candy, sugar-free gum. Check mouth sore
Fluid, fiber, exercises, monitor BM habits, use stool softeners,
27. 27 Interventions for Weight Gain Increase exercises
Reduce calorie diet if indicated
May need to change class of drug
28. 28 AIM- Abnormal Involuntary Movement incidence of TD has been relatively low in recent years, changes in prescribing may result in increased occurrence.
AIMS (Abnormal Involuntary Movement Scale)
http://www.psychiatrictimes.com/scales/movement_disorders/AIMS_LandingPage.jhtml
29. 29 Drug interactions Central nervous system depressants i.e. opiates, barbiturates, alcohol -> sedative effective ?
Antihypertensives - hypotensive effects ?
Caffeine - antipsychotic drug effect ?
Cigarette smoking -blood level of
antipsychotics ?
Lithium - possible additive toxic effect
Anticholinergic - absorption of antipsychotics ? Benzodiazepine group & alcohol
Beta-blockers i.e., clonidine (Catapres)
Benzodiazepine group & alcohol
Beta-blockers i.e., clonidine (Catapres)
30. 30 Anticholinergic drugs - for EPSEs Benztropine (Cogentin): 1-4mg, qd or bid.
PO or IM
Biperiden (Akineton): 2-6mg, qd, bid, tid
Trihexyphenidyl (Artane): 5-15mg/d
Procyclidine (Kemadrin): 6-20mg/d
Ethopropazine (Parsidol): 600mg/d
Anticholinergic drugs ? acetylcholine? Anticholinergic drug ie Cogentin -> impairment in memory & learning
Alzheimer’s dis maybe related to decreased acetylcholine Anticholinergic drug ie Cogentin -> impairment in memory & learning
Alzheimer’s dis maybe related to decreased acetylcholine
31. 31 Other drugs to treat EPSEs Antihistamine
Diphenhydramine (Benadryl) 25-300/d; PO, IM, IV
Dopamine Agonist
Amantadine (Symmetrel) 100-3000mg/d; PO
Benzodiazepines
Diazepam (Valium) 2-6 mg/d; PO, IV
Lorazepam (Ativan) 0.5-2 mg/d; PO, IM
Clonazepam (Klonopin) 1-4; PO
Benadryl has anticholinergic effectBenadryl has anticholinergic effect
32. 32 Types of Antidepressants
Monoamine Oxidase inhibitors (MAO inhibitors)
TCAs (Tricyclic Antidepressants)
SSRI (Selective Serotonin Reuptake
inhibitor)
33. 33 Pt taking Parnate, a MAOI should avoid foods containing tyramine ie cheese, red wine, avocado
MAOI -> hypotension For elderly, Nardil is the most commonly prescribed one for the elderlyPt taking Parnate, a MAOI should avoid foods containing tyramine ie cheese, red wine, avocado
MAOI -> hypotension For elderly, Nardil is the most commonly prescribed one for the elderly
34. 34
35. 35 Other Foods to be avoided – Chocolate, Non-fresh, fermented, or preserved fish, liver, and meats Red wine, Yeast extracts, Yogurt & sour cream, Avocado.
tyramine (amino acid) is the culprit
Other Foods to be avoided – Chocolate, Non-fresh, fermented, or preserved fish, liver, and meats Red wine, Yeast extracts, Yogurt & sour cream, Avocado.
tyramine (amino acid) is the culprit
36. 36 S/S of Hypertensive Crisis on MAOIs Warning S - BP?; palpitations; Headache
Symptoms - sudden BP?;
Explosive occipital headache
Head and face are flushed & feel full
Palpitation, chest pain
Sweating, fever, nausea, vomiting
Dilated pupils, photophobia
37. 37 TX of Hypertensive Crisis on MAOIs Hold MAOIs doses
Do not lie down (elevates BP in head)
IM chlorpromazine 100mg, repeat if necessary (to block norepinephrine)
IV phentolamine, (to bind with norepinephrine receptor sites, blocking norepinephrine)
Manage fever by external cooling techniques
Evaluate diet, adherence, and teaching
38. 38 Pt taking amitriptyline (Elavil) has to be watched for orthostatic hypotension, arrhythmias, and eye painPt taking amitriptyline (Elavil) has to be watched for orthostatic hypotension, arrhythmias, and eye pain
39. 39 Common Side effects of TCAs Mechanism – blockade of acetylcholine
Drowsiness, dizziness, tachycardia, skin rashes, dry moth, constipation, and urinary retention,
Risk of mortality with overdose is high
40. 40
41. 41 A Common side effect of SSRI that pt may be reluctant to report is sexual dysfunctionA Common side effect of SSRI that pt may be reluctant to report is sexual dysfunction
42. 42 Side effects of the SSRI Anxiety & restlessness
Constipation
Dry mouth
Headache
Nausea & vomiting
Sedation
Sexual dysfunction To deal with restlessness of the side effect, the intervention includes decreasing the dosageTo deal with restlessness of the side effect, the intervention includes decreasing the dosage
43. 43 Overview of antidepressants 1st choice - SSRI
Take 2-4 weeks to be effective of TCAs
Abrupt withdrawal of TCAs ?headache, nausea, malaise
MAOIs uses could not take “tyramine” related food ? hypertensive crisis
14 days - change drugs from TCAs to MAOIs
44. 44 Valproic acid (Depakote) is an anticonvulsant. Rapid onset, can be used as initial treatment, effective in bipolar disorder subtype.
Side effects include transient hair loss, wright gain, tremors, GI upset, dose-related throbocytopenia,
Lithium – more than 40 years of clinical experience, most effective for euphoric mania and hypomania, can reduce mortality by decreasing suicide, inexpensive
Side effect include nonresponse in 30-50% of cases, narrow therapeutic index, slow onset of action, side effects very common, high rate of noncompliance, less effective in bipolar subtype.
Carbamazepine: more rapid onset than lithium, maybe effective in difficult-to-treat cases, maybe effective as adjunct therapy in acute mania, generally well tolerated
Side effet: simulates own oxidative metabolism (autoinduction), blood dyscrasias, skin reactions, complex drug interactions, sedation, poor coordination, hyponatremia (poorly tolerated by elderly).
Valproic acid (Depakote) is an anticonvulsant. Rapid onset, can be used as initial treatment, effective in bipolar disorder subtype.
Side effects include transient hair loss, wright gain, tremors, GI upset, dose-related throbocytopenia,
Lithium – more than 40 years of clinical experience, most effective for euphoric mania and hypomania, can reduce mortality by decreasing suicide, inexpensive
Side effect include nonresponse in 30-50% of cases, narrow therapeutic index, slow onset of action, side effects very common, high rate of noncompliance, less effective in bipolar subtype.
Carbamazepine: more rapid onset than lithium, maybe effective in difficult-to-treat cases, maybe effective as adjunct therapy in acute mania, generally well tolerated
Side effet: simulates own oxidative metabolism (autoinduction), blood dyscrasias, skin reactions, complex drug interactions, sedation, poor coordination, hyponatremia (poorly tolerated by elderly).
45. 45 Weight gain is the most popular side effectWeight gain is the most popular side effect
46. 46
47. 47 Use of Lithium Thyroid & kidney screening
Regular levels - prophylactic
Drink a lot of water
No pregnancy -> fetal heart problems
1st trimester -> birth defects
no nursing - excrete from milk
blood volume increase -> hard to measure
no use in age under 8 or in seniors, accumulation in bone tissue, effect of renal & thyroid function; meta? in seniors
48. 48 Side-effect of Lithium Body Image- weight gain ( 60% of pt)
Cardiac - ECG change but not significant
CNS - fine hand tremor (50% of pt); fatigue, headache, mental dullness, lethargy
Skin - acne, rash
Endocrine - hypothyroid (5% of pt); DM
Renal - Polyuria (60% of pt) - H2O?
49. 49 Common causes for Li+? Decrease sodium intake
Fluid and electrolyte loss, sweating,
diarrhea, dehydration, fever, vomiting
Exercise – marathons
Medical illness ie poor renal function
Overdose
Nonsteroidal anti-inflammatory drug therapy Serum level of sodium may affect the maintenance of therapeutic serum levels of lithium
Diuretic therapySerum level of sodium may affect the maintenance of therapeutic serum levels of lithium
Diuretic therapy
50. 50 Ways to maintain Li level Stabilize dosing schedule - dividing doses or use of sustained-release capsules
Ensure adequate dietary sodium and fluid intake (2-3 L/day)
Replace fluid & electrolytes lost during exercise or gastrointestinal illness.
Monitor S/S of lithium side effects and toxicity
Forget dose - retake if <2 hr; skip if >2hr
Never double up
Follow up on lithium level –every 2 months
51. 51
52. 52 Tolerance :
Ativan- short acting benzodiazepines. Metabolized more efficiently
Withdrawal syndrome (including withdrawal seizure) can occur in persons removed form an antianxiety agent after 30 days or more of use, benzodiazpines should be withdrawn slowly over several weeks. Tolerance :
Ativan- short acting benzodiazepines. Metabolized more efficiently
Withdrawal syndrome (including withdrawal seizure) can occur in persons removed form an antianxiety agent after 30 days or more of use, benzodiazpines should be withdrawn slowly over several weeks.
53. 53 Anti-Anxiety drugNon benzodiazepines- Buspirone Buspirone (BuSpar)
not a CNS depressant
less danger of interaction with other CNS depressant i.e. alcohol
no strong sedative-hypnotic effect
Less drowsiness
better tolerated than the benzodiazepines
less potential for addiction Buspirone does not cause drowsiness. Buspirone does not cause drowsiness.
54. 54
55. 55
56. 56 Intervention for Benzodiazepine Withdrawal Symptoms Careful with tolerance, dependency, rebound insomnia/anxiety
Tapered weekly at a rate of 25%
Short-term use
Contraindicated with drug or alcohol abuse
57. 57 Patient Education What the most important thing in medication counseling?
What; How; Why
Common side-effects/ poorly controlled
Health beliefs model – what is the benefits of taking the medication
Relationship between anxiety and physiological reactions - sympathetic nerve system
Relationship between anxiety and physiological reactions - sympathetic nerve system
58. 58 Non-compliance Knowledge - purpose, side-effect,
Pt’s beliefs, wishes, ideas of taking med
Multiple daily dosing schedule
Polypharmacy
History of noncompliance
Social isolation; Expense of drugs
Lack of continuity of care
59. 59 Non-compliance (II) Increased restrictions of pt’s lifestyle
Unsupportive sig. others
Remission of target symptoms
unrealistic expectations
Concurrent substance use
potential stigmatization
60. 60 Have a nice weekend